Robert David Siegel
Professor of Microbiology and Immunology at Stanford University
Robert David Siegel's AcademicInfluence.com Rankings

Download Badge
Biology
Robert David Siegel's Degrees
- PhD Microbiology University of California, Berkeley
Why Is Robert David Siegel Influential?
(Suggest an Edit or Addition)According to Wikipedia, Robert Siegel is a professor at Stanford University with appointments in the Department of Microbiology and Immunology, The Program in Human Biology, the Center for African Studies, and the Woods Institute for the Environment. For more than 20 years, he served as the Course Director of the Infectious Disease component of the preclinical curriculum. He has taught the following Sophomore College courses: The Stanford Safari , Smallpox: Lethal Legacy, Forbidding Future , The Coming Influenza Pandemic , and Measles Sneezes, Things That go Mumps in the Night , and Viruses in the News . Dr. Siegel also teaches a course called Humans and Viruses, which is a curriculum that teaches undergraduate students about all known human viruses. He has led Bing Overseas Study Program overseas seminars to Tanzania, England, Madagascar, the Pantanal, and Tasmania. Siegel served as the second Stanford Tree from 1977-1978.
Robert David Siegel's Published Works
Published Works
- Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). (2015) (703)
- Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. (1992) (536)
- Metformin and cancer: new applications for an old drug (2012) (272)
- Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia. (2010) (169)
- Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia. (1992) (139)
- Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society (2009) (89)
- Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) (2016) (83)
- A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients. (1990) (82)
- Adults with Ewing's Sarcoma: An Analysis of 16 Patients at the Dana‐Farber Cancer Institute (1988) (54)
- The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review (2020) (50)
- Novel Jet-Injection Technology for Nonviral Intratumoral Gene Transfer in Patients with Melanoma and Breast Cancer (2008) (47)
- Effects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients with cancer regarding clinical trial participation: a multicenter randomized controlled trial. (2012) (46)
- Safety of early discharge for low-risk patients with febrile neutropenia: a multicenter randomized controlled trial. (2011) (45)
- Genomic Profiling Reveals the Potential Role of TCL1A and MDR1 Deficiency in Chemotherapy-Induced Cardiotoxicity (2013) (30)
- Use of the nuclease inhibitor aurintricarboxylic acid (ATA) for improved non‐viral intratumoral in vivo gene transfer by jet‐injection (2005) (30)
- Response to Preoperative Short-Course Radiotherapy in Locally Advanced Rectal Cancer: Value of 18F-Fluorodeoxyglucose Positron Emission Tomography (2008) (23)
- Fatal H1N1-Related Acute Necrotizing Encephalopathy in an Adult (2011) (20)
- Recurrent aphthous ulcers in association with HIV infection. (1993) (19)
- Validity and reliability of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). (2012) (14)
- National Collaborative to Improve Oncology Practice: The National Cancer Institute Community Cancer Centers Program Quality Oncology Practice Initiative Experience. (2009) (14)
- A randomized, controlled trial of Panax quinquefolius extract (CVT-E002) to reduce respiratory infection in patients with chronic lymphocytic leukemia. (2012) (14)
- Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples (2021) (12)
- Osteosarcoma in adults. One institution's experience. (1989) (12)
- Thrombocytopenia in the Intensive Care Unit Setting (1990) (12)
- Quality improvement in the national cancer institute community cancer centers program: the quality oncology practice initiative experience. (2015) (10)
- Angiosarcoma of the Forearm Definitively Treated by Hyperfractionated Irradiation (1990) (9)
- A first in human phase I study of receptor tyrosine kinase (RTK) inhibitor MGCD516 in patients with advanced solid tumors. (2015) (8)
- Long-Term Survival in Stage IV Melanoma after Repetitive Surgical Therapy (2008) (8)
- Relapse with Nodular Lymphoma Following Combination Chemotherapy for Diffuse Non‐Hodgkin's Lymphoma (1986) (8)
- Poster SessionP2.06-001 A Study of MGCD516, a Receptor Tyrosine Kinase (RTK) Inhibitor, in Molecularly Selected Patients with NSCLC or Other Advanced Solid Tumors: Topic: Phase I Trials (2017) (7)
- In situ oncocytic change in association with multiple renal cell adenocarcinomas. (1991) (6)
- Complete Response to Dual Immunotherapy in a Young Adult with Metastatic Alveolar Soft Part Sarcoma Enabled by a Drug Recovery Program in a Community Practice. (2019) (6)
- Classification of Human Viruses (2017) (5)
- American Society of Clinical Oncology Quality Care Symposium 2012: re-engineering your practice to deliver quality and value. (2013) (5)
- Tumor lysis syndrome in a nonsmall cell lung cancer. (2014) (5)
- Clinical Course Of Patients with Small Cell Lung Cancer As Second Primary Malignancy (2005) (4)
- Primary squamous cell carcinoma of breast in background of phyllodes tumor--a case report. (2009) (4)
- Real-world Performance of Blood-Based Proteomic Profiling in Frontline Immunotherapy Treatment in Advanced stage NSCLC (2019) (4)
- Phase II Study of Taselisib in PIK3CA-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I (2022) (3)
- Performance of a blood-based test for the detection of multiple cancer types. (2020) (3)
- Evaluation of the spectrum selective RTK inhibitor sitravatinib in clear cell renal cell carcinoma (ccRCC) refractory to anti-angiogenic therapy (AAT). (2018) (3)
- Zollinger-ellison syndrome with subsequent association of insulinoma. (2010) (3)
- Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit (2023) (2)
- Drug Recovery and Copay Assistance Program in a Community Cancer Center: Charity and Challenges. (2019) (2)
- Survival and patterns of relapse following treatment of small-cell lung cancer at a community cancer center. (2001) (2)
- Does home antibiotic therapy increase medical risk for patients with low-risk febrile neutropenia? A multi-institutional randomized trial. (2004) (2)
- A Phase 1b, Open-Label, Dose Escalation and Expansion Study Evaluating the Safety and Efficacy of Entospletinib (GS-9973) with Vincristine and Dexamethasone in Adult Subjects with Relapsed or Refractory Acute Lymphoid Leukemia (ALL) (2015) (2)
- Tracking clinical trial accrual strategies and barriers via a Web-based screening tool. (2016) (2)
- Trials and Tribulations for Adolescents and Young Adults with Cancer: Measuring the Impact of a Community-Based Program. (2017) (2)
- BP1 Regulates PI3K/Akt Pathway by Targeting Vascular Endothelial Growth Factor (VEGF) in Breast Cancer (2018) (2)
- Abstract 3062: miR-671-5p promotes epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer (2015) (2)
- Nonviral gene transfer for cancer gene therapy (2008) (2)
- International Perspective on the Pursuit of Quality in Cancer Care: Global Application of QOPI and QOPI Certification (2020) (1)
- ASCO Quality Care Symposium 2016 Exemplars in Quality and Identifying High-Quality Practice: Delivering Quality in the Community Setting (Bon Secours St Francis Cancer Center). (2016) (1)
- Do We Have Enough Evidence to Propose a Preferred Total Neoadjuvant Therapy Sequence for Patients With Locally Advanced Rectal Cancer? (2022) (1)
- Classification of Human Viruses (2012) (1)
- Oral Chemotherapy Metric Performance in Quality Oncology Practice Initiative Practices: Updated Trends and Analysis. (2022) (1)
- A phase III randomized, double-blind, placebo controlled trial of North American (NA) ginseng (Panax quinquefolium) extract (CVT-E002) in patients with chronic lymphocytic leukemia: Effect on respiratory infection and antibiotic use. (2010) (1)
- Thymoma developing 30 years after mantle radiation for Hodgkin's lymphoma. (2009) (1)
- Improving quality of care within the NCI Community Cancer Centers Program (NCCCP) network. (2013) (0)
- Embedding palliative care (pc) in a community-based cancer center: Benefits and barriers. (2016) (0)
- Contributors (2008) (0)
- Hartford Hospital at a Crossroads (2015) (0)
- Targeting tumors and financial toxicity in AYAs: Exceptional response to dual immunotherapy in an uninsured young adult with soft tissue sarcoma. (2018) (0)
- Sustaining quality cancer care in the NCI Community Cancer Centers Program (NCCCP). (2014) (0)
- Impact of a comprehensive drug recovery system in a community cancer center. (2018) (0)
- 106 The challenges of setting up an inflammatory breast cancer registry (2002) (0)
- GENOMIC ANALYSIS OF CHEMOTHERAPY-INDUCED CARDIOTOXICITY SUGGESTS A POSSIBLE ROLE OF SUPPRESSION OF THE TCL1A/AKT ANTI-APOPTOTIC PATHWAY (2011) (0)
- Contributors (2012) (0)
- Comprehensive genomic profiling of 30,000 consecutive solid tumors (2020) (0)
- Prediction of pan-solid tumor pembrolizumab benefit by integrating tumor mutation and gene expression profiling (2022) (0)
- Associations of Early Completion of Advance Directives With Key End-of-Life Quality Measures: Analysis of an ASCO Quality Oncology Practice Initiative Patient Cohort (2023) (0)
- Nonviral jet-injection gene transfer in patients with in-transit metastases from melanoma and cutaneous metastases from breast cancer: results of a Phase I clinical trial (2008) (0)
- Trisomy 8 as the sole cytogenetic abnormality in an adult patient with acute lymphoblastic leukemia. (2012) (0)
- Contributors (2018) (0)
- Novel Jet-InjectionTechnology for Nonviral Intratumoral Gene Transfer in Patients withMelanoma and Breast Cancer (2008) (0)
- Abstract 2540: miR-196b as a potential biomarker for human esophageal cancer (2017) (0)
- Hematology/Oncology Fellowship Programs' Participation in the Quality Oncology Practice Initiative (2022) (0)
- Steven Karger (1959–2008) (2008) (0)
- Relationship Between Participation in ASCO's Quality Oncology Practice Initiative Program and American Board of Internal Medicine's Maintenance of Certification Program (2022) (0)
- 507TiP PRESERVE 1: A phase III, randomized, double-blind trial of trilaciclib versus placebo in patients receiving FOLFOXIRI/bevacizumab for metastatic colorectal cancer (2021) (0)
- Can measuring quality lead to improvement? Evidence from international participants of ASCO's quality oncology practice initiative (QOPI®) during 2015-2017. (2018) (0)
- Clinical Impact of ASCO Choosing Wisely Guidelines on Staging Imaging for Early-Stage Breast Cancers: A Time Series Analysis Using SEER-Medicare Data (2022) (0)
- Palliative care in the ambulatory setting: Bon Secours St. Francis Hospital (BSSFH). (2017) (0)
- Developing the RECIST Criteria Toolkit NCCCP Sites Use This Tool to Improve Compliance (2011) (0)
- Impact of a comprehensive copay assistance and drug recovery system in a community cancer center. (2018) (0)
- Classification of Viruses (2008) (0)
- The Bon Secours St. Francis Cancer Survivorship Program: A model for community-based multidisciplinary survivorship care. (2016) (0)
- Fertility preservation: Utilizing QOPI metrics in the quality improvement efforts of the NCI Community Cancer Centers Program (NCCCP). (2012) (0)
- Recent developments in medical oncology. (1990) (0)
- AESOP: Phase 2 Open-Label Trial of Avasopasem Manganese (GC4419) for Reduction of Esophagitis in Patients Receiving Chemoradiotherapy for Nonmetastatic Lung Cancer (2022) (0)
This paper list is powered by the following services:
Other Resources About Robert David Siegel
What Schools Are Affiliated With Robert David Siegel?
Robert David Siegel is affiliated with the following schools: